Zhejiang Huakang Pharmaceutical Co Ltd (605077) — Cash Flow Reinvestment Rate
Zhejiang Huakang Pharmaceutical Co Ltd (605077) has a Cash Flow Reinvestment Rate of 20.59x as of December 2024, reinvesting CN¥3.02 Billion (capex CN¥1.43 Billion plus investments CN¥-1.59 Billion) from operating cash flow of CN¥146.50 Million. Check 605077 cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Zhejiang Huakang Pharmaceutical Co Ltd Cash Flow Reinvestment Rate (2016–2024)
Historical reinvestment intensity for Zhejiang Huakang Pharmaceutical Co Ltd across 9 annual periods. Explore Zhejiang Huakang Pharmaceutical Co Ltd (605077) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for Zhejiang Huakang Pharmaceutical Co Ltd (2016–2024)
Year-by-year capital reinvestment analysis for Zhejiang Huakang Pharmaceutical Co Ltd. For live market cap and broader valuation context, see 605077 stock market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 20.59x | CN¥3.02 Billion | CN¥146.50 Million | CN¥1.43 Billion | ▲ +554.2% |
| 2023 | 3.15x | CN¥1.95 Billion | CN¥619.47 Million | CN¥690.70 Million | ▲ +41.8% |
| 2022 | 2.22x | CN¥603.67 Million | CN¥271.98 Million | CN¥539.75 Million | ▼ -63.7% |
| 2021 | 6.11x | CN¥1.62 Billion | CN¥264.32 Million | CN¥360.93 Million | ▲ +240.8% |
| 2020 | 1.79x | CN¥601.43 Million | CN¥335.24 Million | CN¥252.95 Million | ▲ +130.9% |
| 2019 | 0.78x | CN¥218.54 Million | CN¥281.31 Million | CN¥132.21 Million | ▼ -9.8% |
| 2018 | 0.86x | CN¥121.38 Million | CN¥140.97 Million | CN¥121.38 Million | ▲ +320.6% |
| 2017 | 0.20x | CN¥16.49 Million | CN¥80.56 Million | CN¥16.49 Million | ▼ -24.8% |
| 2016 | 0.27x | CN¥25.32 Million | CN¥93.02 Million | CN¥25.32 Million | — |